Australian health officials are in urgent talks about the use of the AstraZeneca vaccine after European medical institutions have issued warnings about the link between vaccines and blood clots.
On Wednesday, the European Medicines Agency (EMA) said blood clotting should be listed as a “very rare” side effect of taking jabs, while women and people under the age of 60 develop symptoms. He said the risk was high. The statement was issued after drug regulators received reports of 169 rare blood clots in people vaccinated with AstraZeneca’s Covid-19 vaccine.
This is compared to 4.8 cases of rare blood clots per million doses administered, said Emer Cooke, director of the European Medicines Agency. Cook confirmed that he was confident that the AstraZeneca vaccine would “save lives.”
Following the announcement of the EMA, the UK announced that it would stop providing the AstraZeneca vaccine to people under the age of 30 and encouraged individuals in the age group to obtain another jab. Denmark and Norway have also postponed vaccine deployment until mid-April. Meanwhile, Germany imposed the latest restrictions on people under the age of 60 at the end of the month after completely suspending vaccine use in March.
In Australia, where most people are set to receive AstraZeneca jabs, health officials will discuss European recommendations on Thursday.
“The AstraZeneca vaccine is effective and very safe for most people. There is this very rare event and some people seem to be associated with that particular vaccine. 4 in 1 million That’s what Chief Medical Officer Paul Kelly said.
“The advantage is that the vaccine is very effective in preventing COVID disease, which can be severe and fatal, especially in the elderly,” he said.
Prime Minister Scott Morrison said the EMA announcement was unlikely to impact national vaccine deployments, as the initial focus was on older Australians. He added that women taking contraceptives and common paracetamol tables are at increased risk of blood clotting.
“We have the best people in the world who are considering these issues to give us the advice of medical professionals,” Morrison said.
Morrison suggested it was too early to say whether Australia would offer another drug to people under the age of 30 or, like some European countries, would add a warning label to the AstraZeneca vaccine.
The state cabinet is set to consider this issue at the next meeting on Friday, and state and federal health ministers will discuss the findings.
Federal opposition leader Anthony Albanese blamed the prime minister, saying the issues surrounding AstraZeneca highlighted the dangers of Australia’s inability to lock vaccine deals with other suppliers.
“The federal government should have secured more deals. There are no deals in Modana. There are no deals in Johnson and Johnson,” he told reporters.
Meanwhile, Queensland Senator Matt Canavan and independent MP Craig Kelly have both declared their support for stopping the use of AstraZeneca jabs.
Former Liberal Party member Kelly resigned from the Liberal Party in February of this year after receiving strong opposition from the media and political opponents for sharing information about the antimalarial drug hydroxychloroquine.
On Wednesday the government said they received 1.3 million locally produced doses, an estimated 920,334 vaccinations were given, Australians report..
Federal Health Minister Greg Hunt said Wednesday, “We expect more than 470,000 times later this week, about 480,000 times early next week, and 670,000 late next week or early next week.” ..
“If that third batch arrives late next week, it means it’s exceeded the one million mark for that week. If it’s passed to the next week, we’ll be in the next week. I will pass it. “